rs758229132
Positions:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_000719.7(CACNA1C):c.340C>A(p.Arg114Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000267 in 1,461,100 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: not found (cov: 34)
Exomes 𝑓: 0.000027 ( 1 hom. )
Consequence
CACNA1C
NM_000719.7 synonymous
NM_000719.7 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.37
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.19).
BP6
Variant 12-2115514-C-A is Benign according to our data. Variant chr12-2115514-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 527091.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=3.37 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. gnomad4_exome allele frequency = 0.0000267 (39/1461100) while in subpopulation AMR AF= 0.000693 (31/44724). AF 95% confidence interval is 0.000502. There are 1 homozygotes in gnomad4_exome. There are 13 alleles in male gnomad4_exome subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAdExome4 at 39 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1C | NM_000719.7 | c.340C>A | p.Arg114Arg | synonymous_variant | 2/47 | ENST00000399655.6 | NP_000710.5 | |
CACNA1C | NM_001167623.2 | c.340C>A | p.Arg114Arg | synonymous_variant | 2/47 | ENST00000399603.6 | NP_001161095.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1C | ENST00000399603.6 | c.340C>A | p.Arg114Arg | synonymous_variant | 2/47 | 5 | NM_001167623.2 | ENSP00000382512.1 | ||
CACNA1C | ENST00000399655.6 | c.340C>A | p.Arg114Arg | synonymous_variant | 2/47 | 1 | NM_000719.7 | ENSP00000382563.1 | ||
CACNA1C | ENST00000682544.1 | c.430C>A | p.Arg144Arg | synonymous_variant | 2/50 | ENSP00000507184.1 | ||||
CACNA1C | ENST00000406454.8 | c.340C>A | p.Arg114Arg | synonymous_variant | 2/48 | 5 | ENSP00000385896.3 | |||
CACNA1C | ENST00000399634.6 | c.340C>A | p.Arg114Arg | synonymous_variant | 2/47 | 5 | ENSP00000382542.2 | |||
CACNA1C | ENST00000683824.1 | c.430C>A | p.Arg144Arg | synonymous_variant | 2/48 | ENSP00000507867.1 | ||||
CACNA1C | ENST00000347598.9 | c.340C>A | p.Arg114Arg | synonymous_variant | 2/49 | 1 | ENSP00000266376.6 | |||
CACNA1C | ENST00000344100.7 | c.340C>A | p.Arg114Arg | synonymous_variant | 2/47 | 1 | ENSP00000341092.3 | |||
CACNA1C | ENST00000327702.12 | c.340C>A | p.Arg114Arg | synonymous_variant | 2/48 | 1 | ENSP00000329877.7 | |||
CACNA1C | ENST00000399617.6 | c.340C>A | p.Arg114Arg | synonymous_variant | 2/48 | 5 | ENSP00000382526.1 | |||
CACNA1C | ENST00000682462.1 | c.430C>A | p.Arg144Arg | synonymous_variant | 2/47 | ENSP00000507105.1 | ||||
CACNA1C | ENST00000683781.1 | c.430C>A | p.Arg144Arg | synonymous_variant | 2/47 | ENSP00000507434.1 | ||||
CACNA1C | ENST00000683840.1 | c.430C>A | p.Arg144Arg | synonymous_variant | 2/47 | ENSP00000507612.1 | ||||
CACNA1C | ENST00000683956.1 | c.430C>A | p.Arg144Arg | synonymous_variant | 2/47 | ENSP00000506882.1 | ||||
CACNA1C | ENST00000399638.5 | c.340C>A | p.Arg114Arg | synonymous_variant | 2/48 | 1 | ENSP00000382547.1 | |||
CACNA1C | ENST00000335762.10 | c.340C>A | p.Arg114Arg | synonymous_variant | 2/48 | 5 | ENSP00000336982.5 | |||
CACNA1C | ENST00000399606.5 | c.340C>A | p.Arg114Arg | synonymous_variant | 2/48 | 1 | ENSP00000382515.1 | |||
CACNA1C | ENST00000399621.5 | c.340C>A | p.Arg114Arg | synonymous_variant | 2/47 | 1 | ENSP00000382530.1 | |||
CACNA1C | ENST00000399637.5 | c.340C>A | p.Arg114Arg | synonymous_variant | 2/47 | 1 | ENSP00000382546.1 | |||
CACNA1C | ENST00000402845.7 | c.340C>A | p.Arg114Arg | synonymous_variant | 2/47 | 1 | ENSP00000385724.3 | |||
CACNA1C | ENST00000399629.5 | c.340C>A | p.Arg114Arg | synonymous_variant | 2/47 | 1 | ENSP00000382537.1 | |||
CACNA1C | ENST00000682336.1 | c.340C>A | p.Arg114Arg | synonymous_variant | 2/47 | ENSP00000507898.1 | ||||
CACNA1C | ENST00000399591.5 | c.340C>A | p.Arg114Arg | synonymous_variant | 2/46 | 1 | ENSP00000382500.1 | |||
CACNA1C | ENST00000399595.5 | c.340C>A | p.Arg114Arg | synonymous_variant | 2/46 | 1 | ENSP00000382504.1 | |||
CACNA1C | ENST00000399649.5 | c.340C>A | p.Arg114Arg | synonymous_variant | 2/46 | 1 | ENSP00000382557.1 | |||
CACNA1C | ENST00000399597.5 | c.340C>A | p.Arg114Arg | synonymous_variant | 2/47 | 1 | ENSP00000382506.1 | |||
CACNA1C | ENST00000399601.5 | c.340C>A | p.Arg114Arg | synonymous_variant | 2/47 | 1 | ENSP00000382510.1 | |||
CACNA1C | ENST00000399641.6 | c.340C>A | p.Arg114Arg | synonymous_variant | 2/47 | 1 | ENSP00000382549.1 | |||
CACNA1C | ENST00000399644.5 | c.340C>A | p.Arg114Arg | synonymous_variant | 2/47 | 1 | ENSP00000382552.1 | |||
CACNA1C | ENST00000682835.1 | c.340C>A | p.Arg114Arg | synonymous_variant | 2/47 | ENSP00000507282.1 | ||||
CACNA1C | ENST00000683482.1 | c.340C>A | p.Arg114Arg | synonymous_variant | 2/47 | ENSP00000507169.1 | ||||
CACNA1C | ENST00000682686.1 | c.340C>A | p.Arg114Arg | synonymous_variant | 2/46 | ENSP00000507309.1 | ||||
CACNA1C | ENST00000682152.1 | c.289C>A | p.Arg97Arg | synonymous_variant | 1/6 | ENSP00000506759.1 | ||||
CACNA1C | ENST00000480911.6 | n.340C>A | non_coding_transcript_exon_variant | 2/27 | 5 | ENSP00000437936.2 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD3 genomes
Cov.:
34
GnomAD3 exomes AF: 0.000122 AC: 30AN: 246874Hom.: 1 AF XY: 0.0000521 AC XY: 7AN XY: 134430
GnomAD3 exomes
AF:
AC:
30
AN:
246874
Hom.:
AF XY:
AC XY:
7
AN XY:
134430
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000267 AC: 39AN: 1461100Hom.: 1 Cov.: 32 AF XY: 0.0000179 AC XY: 13AN XY: 726872
GnomAD4 exome
AF:
AC:
39
AN:
1461100
Hom.:
Cov.:
32
AF XY:
AC XY:
13
AN XY:
726872
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 34
GnomAD4 genome
Cov.:
34
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Long QT syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 15, 2023 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 10, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at